Specific protein expression refers to the rational design and execution of expression strategies tailored to the unique structural, functional, or regulatory requirements of a target protein. Unlike conventional "one-system-fits-all" expression approaches, specific expression focuses on controlling protein assembly, stoichiometry, solubility, stability, and biological activity through customized vector design, host selection, and expression architecture.
Profacgen offers a comprehensive portfolio of specific protein expression services, enabling the reliable production of complex, multimeric, antibody-based, or otherwise challenging recombinant proteins. By integrating advanced expression systems—including proprietary platforms, fusion strategies, co-expression designs, and antibiotic-free systems—we deliver functional proteins optimized for research, diagnostics, and therapeutic development.
Many recombinant proteins cannot be successfully produced using standard expression workflows. Challenges frequently arise due to:
Specific protein expression addresses these issues by engineering the expression strategy around the protein, rather than forcing the protein into a generic system. This approach is especially critical for:
By tailoring expression design at the genetic, cellular, and process levels, specific expression significantly improves success rates and protein quality.
Profacgen provides an integrated suite of specific protein expression services, built on proven methodologies used by leading biotechnology and pharmaceutical organizations. Each service is designed to solve a distinct expression challenge while maintaining flexibility for customization.
Recombinant Antibody Production Services
Profacgen offers recombinant antibody expression services optimized for correct heavy and light chain assembly, folding, and biological activity.
Supported Formats:
Expression strategies are selected to ensure high-quality antibodies suitable for research, diagnostic, or therapeutic development.
Fusion protein expression is a powerful strategy for improving recombinant protein performance. Fusion partners can enhance solubility, stabilize folding intermediates, or simplify purification workflows.
Applications:
Fusion constructs are carefully designed to ensure that biological activity is preserved or restored after expression.
Protein co-expression enables the simultaneous production of multiple interacting proteins or subunits within the same expression host. This approach is essential for protein complexes where individual subunits are unstable when expressed alone.
Capabilities:
Co-expression significantly improves assembly efficiency and functional integrity of protein complexes.
Trimeric Protein Production Service
Many biologically important proteins function as trimers, and incorrect oligomerization often leads to loss of activity. Profacgen provides targeted strategies to promote correct trimer formation during expression.
Key Advantages:
This service is ideal for receptors, viral proteins, and signaling molecules requiring precise oligomeric states.
Antibiotic-Free Expression System
Antibiotic-free expression systems eliminate the use of antibiotic resistance markers, improving production safety, regulatory compatibility, and genetic stability.
Benefits:
This system is particularly valuable for large-scale production and therapeutic research applications.
The NovEgg Expression System is designed to overcome expression bottlenecks associated with unstable or low-yield proteins. By optimizing transcriptional control and translation efficiency, this system enhances protein accumulation while minimizing degradation.
Key Features:
Across all specific expression services, Profacgen provides:
Client Requirements:
A university research group required the production of a trimeric signaling protein for functional and interaction studies. Using standard recombinant expression systems, the protein was expressed but showed inconsistent oligomerization, resulting in heterogeneous mixtures of monomers, dimers, and higher-order aggregates. This structural inconsistency led to reduced biological activity and poor reproducibility in downstream assays.
Our Solution:
Profacgen applied a dedicated trimeric protein production strategy, including optimized vector design and expression architecture to promote controlled trimer assembly during protein synthesis. Expression conditions were fine-tuned to stabilize the native oligomeric state and minimize misassembly.
Final Results:
The target protein was produced predominantly in its native trimeric form with significantly improved structural homogeneity. Functional assays confirmed restored biological activity and improved experimental consistency.
Client Requirements:
A biotechnology company encountered severe solubility issues when expressing a recombinant protein in a bacterial expression system. The majority of the expressed protein formed insoluble aggregates, resulting in low recovery after purification and preventing downstream biochemical and functional studies.
Our Solution:
We implemented a fusion protein expression strategy using a carefully selected solubility-enhancing fusion partner. Expression parameters, including induction conditions and fusion orientation, were optimized to support proper folding while maintaining the functional integrity of the target protein.
Final Results:
Protein solubility increased substantially, enabling efficient purification under native conditions. The recovered protein demonstrated improved stability and was successfully applied in downstream functional and interaction studies, meeting the client's research objectives.
Consult Our Experts on Your Project
Fill out this form and one of our experts will respond to you within one business day.